1. EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR

    Novak, D. D., Troitskaya, O. S., Nushtaeva, A. A., Zhilnikova, M. V., Richter, V. A., Meschaninova, M. I. & Koval, O. A., 2023, In: Acta Naturae. 15, 2, p. 59-69 11 p., 7.

    Research output: Contribution to journalArticlepeer-review

  2. Egfr transgene stimulates spontaneous formation of mcf7 breast cancer cells spheroids with partly loss of her3 receptor

    Troitskaya, O., Novak, D., Nushtaeva, A., Savinkova, M., Varlamov, M., Ermakov, M., Richter, V. & Koval, O., 1 Dec 2021, In: International Journal of Molecular Sciences. 22, 23, 12937.

    Research output: Contribution to journalArticlepeer-review

  3. Enhancement of the Anticancer Effect during the Simultaneous Treatment of Cells by a Cold Atmospheric Plasma Jet and Gold Nanoparticles

    Schweigert, I., Zakrevsky, D., Milakhina, E., Gugin, P., Biryukov, M., Polyakova, A., Kryachkova, N., Gorbunova, E., Epanchintseva, A., Pyshnaya, I. & Koval, O., 1 Nov 2024, In: Plasma Physics Reports. 50, 11, p. 1375-1387 13 p.

    Research output: Contribution to journalArticlepeer-review

  4. Establishment of primary human breast cancer cell lines using "pulsed hypoxia" method and development of metastatic tumor model in immunodeficient mice

    Nushtaeva, A. A., Karpushina, A. A., Ermakov, M. S., Gulyaeva, L. F., Gerasimov, A. V., Sidorov, S. V., Gayner, T. A., Yunusova, A. Y., Tkachenko, A. V., Richter, V. A. & Koval, O. A., 28 Feb 2019, In: Cancer Cell International. 19, 1, p. 46 19 p., 46.

    Research output: Contribution to journalArticlepeer-review

  5. IDO inhibitors increase the antitumor immunity of ICD-dying cells

    Troitskaya, O., Varlamov, M., Kuligina, E., Richter, V. & Koval, O., Jul 2021, In: FEBS Open Bio. 11, p. 401-402 2 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  6. Immunogenic Cell Death in Cancer Therapy

    Troitskaya, O. S., Novak, D. D., Richter, V. A. & Koval, O. A., 21 Apr 2022, In: Acta Naturae. 14, 1, p. 40-53 14 p., 4.

    Research output: Contribution to journalArticlepeer-review

  7. Immunogenicity of recombinant analog of antitumor protein lactaptin

    Tkachenko, A. V., Troitskaya, O. S., Semenov, D. V., Dmitrienko, E. V., Kuligina, E. V., Richter, V. A. & Koval, O. A., 1 Sept 2017, In: Molecular Biology. 51, 5, p. 687-694 8 p.

    Research output: Contribution to journalArticlepeer-review

  8. Immunogenicity of recombinant analog of antitumor protein lactaptin

    Tkachenko, A. V., Troitskaya, O. S., Semenov, D. V., Dmitrienko, E. V., Kuligina, E. V., Richter, V. A. & Koval, O. A., 9 Nov 2017, In: Molekuliarnaia biologiia. 51, 5, p. 787-796 10 p.

    Research output: Contribution to journalArticlepeer-review

  9. Immunological Effects of Cold Atmospheric Plasma-Treated Cells in Comparison with Those of Cells Treated with Lactaptin-Based Anticancer Drugs

    Troitskaya, O., Novak, D., Varlamov, M., Biryukov, M., Nushtaeva, A., Kochneva, G., Zakrevsky, D., Schweigert, I., Richter, V. & Koval, O., Sept 2022, In: Biophysica. 2, 3, p. 266-280 15 p.

    Research output: Contribution to journalArticlepeer-review

  10. Implication of immune system in Vaccinia virus-induced cell death

    Koval, O., Kochneva, G., Troitskaya, O., Tkachenko, A., Nushtaeva, A., Kuligina, E. & Richter, V., 3 Jan 2019, In: Cell Death Discovery. 5, 2 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

ID: 3445280